Melanie Märklin

32PUBLICATIONS
143CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical infection agents (incl. prions)Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Aug 18, 2026
Soluble PD-L1 as prognostic biomarker in acute myeloid leukemia.

|Feb 19, 2026
Enhancing NK Cell Activity in Colorectal Cancer with an Fc-Optimized Antibody Targeting CD276 (B7-H3).

Sylwia A Stefańczyk, Xenija Kaiser, Ilona Hagelstein

|Oct 03, 2025
FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid Leukemia.

Melissa Zwick, Bastian Zinkel, Corinna Spohr

|Jan 17, 2025
First-in-class ultralong-target-residence-time p38α inhibitors as a mitosis-targeted therapy for colorectal cancer.

Ramona Rudalska, Jule Harbig, Michael Forster

|Jul 13, 2024
Expression and Prognostic Value of a Novel B7-H3 (CD276) Antibody in Acute Myeloid Leukemia.

Sylwia A Stefańczyk, Clara Hayn, Jonas Heitmann

|Apr 18, 2024
Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody.

Sylwia A Stefańczyk, Ilona Hagelstein, Martina S Lutz

Pageof 6

Frequent Collaborators

13 joint publications

Helmut R Salih

9 joint publications

Juliane S Walz

9 joint publications

Annika Nelde

6 joint publications

Jonas S Heitmann